Heart Failure as First Sign of Development of Cardiac Metastases in a Patient with Diagnosis of Papillary Thyroid Carcinoma on Treatment with Tyrosine-Kinase Inhibitors: Differential Diagnoses and Clinical Management

Publisher： Karger

E-ISSN： 1662-6575|7|2|591-599

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.2, 2014-08, pp. : 591-599

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib Malate, a Receptor Tyrosine Kinase Inhibitor, Is Effective in the Treatment of Restrictive Heart Failure due to Heart Metastases from Renal Cell Carcinoma

By  

Cardiology, Vol. 114, Iss. 1, 2009-04 ,pp. : 67-71

Karger

Access to resources Recommend Favorite

HER-Targeted Tyrosine-Kinase Inhibitors

By  

Oncology, Vol. 63, Iss. 1, 2002-11 ,pp. : 6-16

Karger

Access to resources Recommend Favorite

Cardiac Metastases of Renal Cell Carcinoma Revealed by Syncope: Diagnosis and Treatment

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-08 ,pp. : 560-564

Karger

Access to resources Recommend Favorite

The impact of locoregional recurrences and distant metastases on the survival of patients with papillary thyroid carcinoma

By  

CLINICAL ENDOCRINOLOGY, Vol. 82, Iss. 2, 2015-02 ,pp. : 286-294

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trends in the Clinical Characteristics of Patients with Papillary Thyroid Carcinoma in Taiwan

By  

Oncology, Vol. 58, Iss. 4, 2000-05 ,pp. : 280-285

Karger

Access to resources Recommend Favorite